SAP and AstraZeneca Expand Their Collaboration
As part of its Axial transformation program, the British-Swedish pharmaceutical company is transitioning from its existing SAP ERP Central Component systems to SAP Cloud ERP Private.

SAP and AstraZeneca are further expanding their partnership, which has been in place for 20 years. As part of the "RISE with SAP" program, the pharmaceutical company, headquartered in Cambridge, England, is migrating to SAP Cloud ERP Private. The company-wide migration involves one of the largest SAP system landscapes in the life sciences industry. AstraZeneca aims to simplify and further standardize its IT landscape. More uniform systems, data, and processes are intended to help the company respond more quickly to changes and make decisions based on more reliable information.
As part of its own transformation program, Axial, AstraZeneca is transitioning from existing SAP ERP Central Component systems to SAP Cloud ERP Private. The company aims to further standardize work practices, harmonize data, and better integrate processes across the enterprise.
“SAP has been an integral part of our business processes for more than two decades,” said Chris Taylor, Chief Information Officer at AstraZeneca. “The next chapter of our partnership is about much more than just modernizing our technology. With Axial, we’re simplifying our operations while also paving the way for more extensive use of AI. After all, the faster we translate insights into concrete action, the sooner we can derive benefits for our company and for patients.”
AstraZeneca is also exploring various applications of SAP’s Business AI. These include the Industry AI portfolio, Joule, and agent-based AI applications in finance, supply chain, and manufacturing. These solutions can help increase productivity, improve data quality and data governance, and accelerate decision-making processes.

With SAP Business Data Cloud, AstraZeneca can consolidate data from various sources, thereby building a consistent and reliable data foundation for future AI applications. SAP Green Ledger enables the company to link sustainability and business data across the value chain. This allows sustainability considerations to be directly integrated into business processes and decisions.
“In the life sciences and healthcare industries, companies must manage growing complexity while driving innovation,” explained Thomas Saueressig, Chief Customer Officer and member of the SAP Executive Board. “AstraZeneca demonstrates how the cloud, data, and AI can be integrated to achieve this. By simplifying processes, speeding up decisions, and making data more usable, we’re helping AstraZeneca focus more on what makes a difference: driving scientific progress and bringing new medicines to patients.”















